The Deal: Q1 2017

• Overall deal numbers increased by 2.7% from the previous quarter. However, deal numbers were still 6.72% lower than in the same quarter last year.

• The total amount invested increased by 2.2%, the highest amount since Q1 last year.

• However, growth in deal numbers was only seen in early-stage deals.

• Growth was seen in medical technology and life sciences, with 3 of the quarter’s 5 biggest deals in this space.

• Crowdfunding saw almost £45m invested over 80 deals, an 11% growth in deal numbers. Again, growth was only seen in early-stage deals.

Download the report here